Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype.
暂无分享,去创建一个
I. Bruce | M. Lunt | L. Teh | R. Bernstein | Y. Ahmad | M. Pattrick | H. Bodill | J. Shelmerdine | L. Teh | M. G. Walker
[1] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[2] J. Reveille,et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. , 2004, Arthritis and rheumatism.
[3] I. Bruce,et al. Systemic Lupus Erythematosus: An Independent Risk Factor for Endothelial Dysfunction in Women , 2004, Circulation.
[4] J. Schwartz,et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.
[5] Paolo Raggi,et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.
[6] I. Bruce,et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. , 2003, Arthritis and rheumatism.
[7] Y. Shoenfeld,et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus , 2003, Annals of the rheumatic diseases.
[8] M. Monestier,et al. Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody. , 2003, Arthritis and rheumatism.
[9] D. Isenberg,et al. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. , 2003, Rheumatology.
[10] V. Brancaccio,et al. Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies , 2002, Lupus.
[11] D. Gladman,et al. Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.
[12] A. Hamsten,et al. Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus , 2001, Circulation.
[13] J. Jeng,et al. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. , 2001, Atherosclerosis.
[14] M. Abrahamowicz,et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. , 2001, Arthritis and rheumatism.
[15] I. Bruce,et al. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. , 2000, The Journal of rheumatology.
[16] R. Neary,et al. Risk in cardiovascular disease , 2000, BMJ : British Medical Journal.
[17] Durrington Pn. Risk in cardiovascular disease. Joint British societies recommend their computer program for risk calculations. , 2000 .
[18] W A Wilson,et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.
[19] D. Renlund,et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. , 1998, Transplantation.
[20] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[21] D. Gladman,et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[22] R. D'Agostino,et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.
[23] Z. Makita,et al. Involvement of β2‐glycoprotein I and anticardiolipin antibodies in oxidatively modified low‐density lipoprotein uptake by macrophages , 1997, Clinical and experimental immunology.
[24] P. Metcalf,et al. B‐Mode‐Detected Carotid Artery Plaque in a General Population , 1994, Stroke.
[25] R. Lahita,et al. Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus. , 1993, Arthritis and rheumatism.
[26] M. Petri,et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. , 1992, The American journal of medicine.
[27] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[28] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[29] L. Kuller,et al. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. , 2004, Arthritis and rheumatism.
[30] P. Sidhu,et al. A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. , 1997, The British journal of radiology.
[31] W Riley,et al. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. , 1996, Stroke.
[32] W. Mckinney,et al. Risk factors for site specific extracranial carotid artery plaque distribution as measured by B-mode ultrasound. , 1989, Journal of clinical epidemiology.